In the Hypertension article by Tian et al (Tian J, Shidyak A, Periyasamy SM, Haller S, Taleb M, El-Okdi N, Elkareh J, Gupta S, Gohara S, Fedorova OV, Cooper CJ, Xie Z, Malhotra D, Bagrov AY, Shapiro JI. Spironolactone Attenuates Experimental Uremic Cardiomyopathy by Antagonizing Marinobufagenin. Hypertension. 2009;54:1313–1320), corrections have been made to Figure 2A. The representative Western blot was not a correct blot in the published article. This change affects none of the observations or conclusions made in the article.
The authors regret the error.
These corrections have been made to the current online version of the article, which is available at http://hyper.ahajournals.org/cgi/content/full/54/12/1313.
- © 2011 American Heart Association, Inc.